Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

IGF-1 is an essential neurotrophin produced peripherally and in the brain. Impairments in the brain IGF-1 concentrations might be responsible for some aspects of major depressive disorder (MDD) pathogenesis, w...

Source: BMC Psychiatry - May 8, 2020 Category: Psychiatry Authors: Oleg A. Levada, Alexandra S. Troyan and Irina Y. Pinchuk Tags: Research article Source Type: research